» Articles » PMID: 29564405

Orbital Invasion of Ameloblastoma: A Systematic Review Apropos of a Rare Entity

Abstract

Purpose: Ameloblastoma is a non-encapsulated and slow-growing tumor with high recurrence rate. Orbital involvement by this neoplasm is an extremely rare entity. In this study, we present a systematic review on this situation along with clinical and paraclinical features of a case.

Methods: An electronic search was conducted on major medical sources. Data of the cases in the literature in addition to our own case were extracted, summarized, and statistically analyzed.

Results: A total of 36 other cases from 20 relevant studies were also reviewed. Review topics included epidemiology, clinical presentation, pathologic features, differential diagnosis, imaging, treatment, and prognosis. We provided a five-year history of a 50-year-old man with orbital/skull base invasion of plexiform maxillary ameloblastoma.

Conclusions: Maxillary ameloblastoma is a locally aggressive neoplasm, and physicians must be alert to the biologic behavior of this tumor to detect any invasion to critical structures such as orbit and cranium. Orbital ameloblastoma causes significant morbidity and mortality. We advocate meticulous patient follow-up with regular clinical examinations and paraclinical work-up for timely detection of any invasion or recurrence. The best must be done to avoid extensions by aggressive removal of maxillary ameloblastoma.

Citing Articles

Dentigerous Cyst Masquerading as Lacrimal Sac Diverticulitis.

Doctor S, Agarwal A, Ali M, Bothra N Case Rep Ophthalmol. 2025; 16(1):95-101.

PMID: 39981541 PMC: 11842074. DOI: 10.1159/000543279.


Maxillary Ameloblastoma with Local Recurrence, Orbital Invasion, and Systemic Metastases: A Case Report and Review of the Literature.

Linaburg T, Araya J, Briceno C Case Rep Ophthalmol. 2024; 15(1):238-245.

PMID: 38504671 PMC: 10950358. DOI: 10.1159/000537707.


Implant-supported prosthetic rehabilitation after Ameloblastomas treatment: a systematic review.

Alarcon-Sanchez M, Becerra-Ruiz J, Yessayan L, Mosaddad S, Heboyan A BMC Oral Health. 2023; 23(1):1013.

PMID: 38110933 PMC: 10729555. DOI: 10.1186/s12903-023-03765-7.


Pathogenesis and characteristics of large ameloblastoma of the jaw: a report of two rare cases.

Qiao X, Niu X, Liu J, Chen L, Guo Y, Zhong M J Int Med Res. 2021; 49(5):3000605211014803.

PMID: 34034548 PMC: 8161878. DOI: 10.1177/03000605211014803.


Maxillary Ameloblastoma: A Review With Clinical, Histological and Prognostic Data of a Rare Tumor.

Evangelou Z, Zarachi A, Dumollard J, Peoch M, Komnos I, Kastanioudakis I In Vivo. 2020; 34(5):2249-2258.

PMID: 32871747 PMC: 7652510. DOI: 10.21873/invivo.12035.

References
1.
Brazis P, Miller N, Lee A, Holliday M . Neuro-ophthalmologic Aspects of Ameloblastoma. Skull Base Surg. 1995; 5(4):233-44. PMC: 1656531. DOI: 10.1055/s-2008-1058921. View

2.
Sehdev M, Huvos A, Strong E, GEROLD F, Willis G . Proceedings: Ameloblastoma of maxilla and mandible. Cancer. 1974; 33(2):324-33. DOI: 10.1002/1097-0142(197402)33:2<324::aid-cncr2820330205>3.0.co;2-u. View

3.
Ackermann G, Altini M, Shear M . The unicystic ameloblastoma: a clinicopathological study of 57 cases. J Oral Pathol. 1988; 17(9-10):541-6. DOI: 10.1111/j.1600-0714.1988.tb01331.x. View

4.
Kaye F, Ivey A, Drane W, Mendenhall W, Allan R . Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma. J Natl Cancer Inst. 2014; 107(1):378. DOI: 10.1093/jnci/dju378. View

5.
Ciment L, Ciment A . Malignant ameloblastoma metastatic to the lungs 29 years after primary resection: a case report. Chest. 2002; 121(4):1359-61. DOI: 10.1378/chest.121.4.1359. View